AstraZeneca/Daiichi-Sankyo

FDA approves Enhertu for HER2-low breast cancer

lab microscope

Accelerating R&D with FAIR data

Kallyope

Kallyope’s focus on the gut-brain axis yields a diverse portfolio

ChemoCentryx/Amgen

Amgen to pay almost $4B for ChemoCentryx

Axcella

Axcella touts positive results from Phase 2a long COVID study

artificial intelligence

Defining complexity: A framework to identify complex clinical trials and set them up for success

CRB

Meet CRB’s new director of procurement 

BioVectra

BioVectra chief commercial officer has played a pivotal role in firm’s success

clinical trial

What biopharmas should know about RBM and RBQM